000 01442 a2200361 4500
005 20250516144352.0
264 0 _c20131108
008 201311s 0 0 eng d
022 _a1432-1041
024 7 _a10.1007/s00228-013-1502-z
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFranz, Carmen C
245 0 0 _aDose adjustment in patients with liver cirrhosis: impact on adverse drug reactions and hospitalizations.
_h[electronic resource]
260 _bEuropean journal of clinical pharmacology
_cAug 2013
300 _a1565-73 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xadverse effects
650 0 4 _aCross-Sectional Studies
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
_xepidemiology
650 0 4 _aHospitalization
_xstatistics & numerical data
650 0 4 _aHumans
650 0 4 _aLiver Cirrhosis
_xmetabolism
650 0 4 _aPeritonitis
_xepidemiology
650 0 4 _aProton Pump Inhibitors
_xadverse effects
650 0 4 _aRetrospective Studies
700 1 _aHildbrand, Carole
700 1 _aBorn, Christa
700 1 _aEgger, Sabin
700 1 _aRätz Bravo, Alexandra E
700 1 _aKrähenbühl, Stephan
773 0 _tEuropean journal of clinical pharmacology
_gvol. 69
_gno. 8
_gp. 1565-73
856 4 0 _uhttps://doi.org/10.1007/s00228-013-1502-z
_zAvailable from publisher's website
999 _c22671749
_d22671749